-
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Giovanni O. Palladini, Efstathios Kastritis, Mathew S. Maurer, Jeffrey A. Zonder, Monique C. Minnema, Ashutosh D. Wechalekar, +14 more
212citations -
Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation2020 Blood article Biochemistry, Genetics and Molecular Biology Genetic Associations and Epidemiology Open access cited by 2 patents
Louisa Goumidi, Florian Thibord, Kerri L. Wiggins, Ruifang Li‐Gao, Mickael R. Brown, Astrid van Hylckama Vlieg, +22 more
48citations -
The Clinical Picture of the ERCC6L2 Disease - from Bone Marrow Failure to Acute Leukemia2023 Blood article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Marja Hakkarainen, Ilse Kaaja, Suvi P. M. Douglas, Thomas J. Vulliamy, Inderjeet S Dokal, Jean Pierre Soulier, +23 more
42citations -
Reduction in Absolute Involved Free Light Chain and Difference between Involved and Uninvolved Free Light Chain Is Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Bortezomib, Cyclophosphamide, and Dexamethasone with or without Daratumumab: Results from Andromeda2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +27 more
15citations -
Subcutaneous Daratumumab (DARA) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival and Final Major Organ Deterioration Progression-Free Survival Results from the Phase 3 Andromeda Study2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Efstathios Kastritis, Giovanni O. Palladini, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, Hans Chulhee Lee, +24 more
15citations -
Subcutaneous Daratumumab with Bortezomib, Cyclophosphamide, and Dexamethasone in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: 18-Month Analysis of the Phase 3 ANDROMEDA Study2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Raymond L. Comenzo, Giovanni O. Palladini, Efstathios Kastritis, Monique C. Minnema, Ashutosh D. Wechalekar, Arnaud Jaccard, +24 more
12citations -
Enhanced α2-3–linked sialylation determines the extended half-life of CHO-rVWF2025 Blood article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access
Ciara Byrne, Soracha E. Ward, Jamie M. O’Sullivan, Alain Chion, Patrícia das Dores Lopes, Bogdan Baci, +13 more
10citations -
Health-Related Quality of Life in Patients with AL Amyloidosis Treated with Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone: Results from the Phase 3 Andromeda Study2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Vaishali Sanchorawala, Giovanni O. Palladini, Monique C. Minnema, Arnaud Jaccard, Hans Chulhee Lee, Simon DJ Gibbs, +28 more
7citations -
Rapid and Deep Hematologic Responses Are Associated with Improved Major Organ Deterioration Progression-Free Survival in Newly Diagnosed AL Amyloidosis: Results from Andromeda2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Ashutosh D. Wechalekar, Giovanni O. Palladini, Giampaolo Merlini, Raymond L. Comenzo, Arnaud Jaccard, NamPhuong Tran, +6 more
6citations -
Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Cell death mechanisms and regulation
Shukaib Arslan, Giovanni Marconi, Giovanni Martinelli, Shaun A. Fleming, Antonio Curti, Shira Naomi Dinner, +19 more
5citations -
Outcomes By Cardiac Stage in Newly Diagnosed AL Amyloidosis: Results from Andromeda2020 Blood article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Monique C. Minnema, Angela A. Dispenzieri, Giampaolo Merlini, Raymond L. Comenzo, Efstathios Kastritis, Ashutosh D. Wechalekar, +10 more
5citations -
Artificial Intelligence Approach for the Discovery of Autoantigen Recognition By B-Cell Lymphomas2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology vaccines and immunoinformatics approaches
David Medina, Julieta Sepúlveda-Yáñez, Diego Álvarez-Saravia, Roberto Uribe-Paredes, Hendrik Veelken, Marcelo A. Navarrete
3citations -
Real-Life Data of Cyclosporine (CsA) Tapering in Patients with Very/ Severe Aplastic Anemia (v/sAA) Treated with Horse Anti-Thymocyte Globulin (hATG/CsA) Suggest Higher Risk of AA Relapse at Cyclosporine Plasma Levels below 100 Nanogram per Milliliter2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments
Jeanette Walter, Kim Kricheldorf, Yannic Schumacher, Susanne Isfort, Jörg Chromik, Beatrice Drexler, +4 more
2citations -
Subcutaneous Daratumumab (DARA SC) + Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Asian Patients with Newly Diagnosed Light Chain (AL) Amyloidosis: Subgroup Analysis from the Phase 3 Andromeda Study2020 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Kenshi Suzuki, Ashutosh D. Wechalekar, Kihyun Kım, Chihiro Shimazaki, Jin Seok Kim, Takayuki Ikezoe, +15 more
2citations -
Optimization of Targeted Lipid Nanoparticle for the Treatment of RUNX1::ETO Driven AML2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery Open access
L. Daniel Mata Casimiro, Manisha du Plessis, Dennis Unthan, Heyang Zhang, Matthias Barz, Raymond Michel Schiffelers, +1 more
2citations -
Specific Gut Microbiome Changes in Myelodysplastic Neoplasms Linked to Inflammation2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Gut microbiota and health
Ekaterina Balaian, Katja Sockel, Manja Wobus, Maria Uhlig, Matthias Wolfgang Groß, Sebastian Zeißig, +3 more
2citations -
Human precursor labeling in situ reveals a conveyor belt differentiation trajectory and a 6-day neutrophil life span2026 Blood article Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Erinke van Grinsven, Tamar Tak, Marwan Hassani, Selma van Staveren, Suzanne Bongers, Joris Bekkers, +9 more
1citations -
Tandem Substitutions in Somatic Hypermutation2021 Blood conference-abstract Biochemistry, Genetics and Molecular Biology DNA Repair Mechanisms Open access
Marvyn T. Koning, Julieta Sepúlveda-Yáñez, Diego Álvarez-Saravia, Bas Pilzecker, Pauline A. van Schouwenburg, Mirjam van der Burg, +3 more
1citations -
Phase 2 Study of Daratumumab (DARA) Plus Bortezomib, Cyclophosphamide, and Dexamethasone (D-VCd) in a Diverse Patient Population with Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis: Aquarius2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes
Michael Alan Rosenzweig, Yvonne Adeduni Efebera, Efstathios Kastritis, Brandon Jamaal Blue, Faizi A. Jamal, Monique C. Minnema, +10 more
1citations -
Single-Cell-Multiomics Demonstrates Molecular Efficacy of a Clinical Lentiviral Vector for Gene Therapy of RPS19-Deficient Diamond-Blackfan Anemia2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Virus-based gene therapy research
Sofia Freiman, Jun Chen, Johan Flygare, Chayenne Kampman, Karin Pike‐Overzet, Alexander B. Mohseny, +6 more
1citations -
Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race Study2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments
Antonio Maria Risitano, Simona Iacobelli, Austin Gladston Kulasekararaj, Marleen van Os, Morag Griffin, Constantijn J.M. Halkes, +43 more
1citations -
CSF3RT618I Is Stabilized By Calnexin and Induces Unfolded Protein Response (UPR) and ER-Phagy: A Pro-Survival Pathway for Oncogenic Misfolded CSF3R Proteins in Chronic Neutrophilic Leukemia (CNL)2024 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Endoplasmic Reticulum Stress and Disease
Alessandra Hartke, Axel Künstner, Anke Fähnrich, Hauke S. Busch, Timo Gemoll, Jasmin Osius, +10 more
0citations